A few recent articles address the fact there is no way to quickly restore normal clotting for patients in need of emergency surgery or to stop a major bleeding episode while on Eliquis, Savaysa, and Xarelto.
What makes these articles interesting is that they are from the perspective of medical doctors who might prescribe Eliquis, Savaysa, and Xarelto as well as emergency room doctors who may have to treat patients on these newer anticoagulant medicines.
From the this December 23, 2015 Reuters news report, “New blood thinner ‘antidote’ to help doctors move past warfarin”, we get some insight about this current “no antidote” situation:
“It may be uncommon, but they’re memorable when they happen,” Dr. Charles Pollack, an emergency physician at Thomas Jefferson University Hospital in Philadelphia, said of major bleeding events.
“We didn’t have a specific reversal strategy for these drugs, and I think that left people feeling a bit insecure,” added Pollack, who has done clinical work on a recently approved antidote to Boehringer Ingelheim’s rival blood clot preventer Pradaxa….
“I have many physicians, particularly surgeons, who hate these drugs. They’re frightened of them because they’ve had to deal with the consequences of somebody coming in with trauma,” while using the new blood thinners.
And as regards how that need for an antidote for Eliquis, Savaysa, and Xarelto has come to be realized by doctors, from this Original Article piece, “Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity”, published in the December 17, 2015 edition of The New England Journal of Medicine:
Anticoagulation-related major bleeding is associated with an increased risk of death and thrombotic events, independent of the class of anticoagulant used. Patients who receive factor Xa inhibitors may also be at increased risk for bleeding if emergency surgery is required. With the increasing use of factor Xa inhibitors, the number of patients who require reversal of the anticoagulant effects is anticipated to rise. Therefore, a specific antidote that can rapidly reverse the anticoagulant effects of factor Xa inhibitors in patients who are bleeding or who require emergency surgery is needed. [footnotes omitted]
We are currently investigating potential drug injury lawsuits involving Eliquis, Savaysa, and Xarelto for patients who had uncontrollable bleeding, some of whom died, unfortunately.
[Read this article in full at original source]_______________________________________________________________________
Free Eliquis Case Evaluation
Strictly Confidential, No Obligation
______________________________________________________________________
Free Savaysa Case Evaluation
Strictly Confidential, No Obligation
_______________________________________________________________________
Free Xarelto Case Evaluation
Strictly Confidential, No Obligation
______________________________________________________________________